Supplemental material
Open access
2,753
Views
46
CrossRef citations to date
0
Altmetric
Commentary
A two-dose heterologous prime-boost vaccine regimen eliciting sustained immune responses to Ebola Zaire could support a preventive strategy for future outbreaks
Georgi ShukarevJanssen Vaccines AG, Bern, SwitzerlandCorrespondence[email protected]
, Benoit CallendretJanssen Vaccines & Prevention B.V., Leiden, The Netherlands
, Kerstin LuhnJanssen Vaccines & Prevention B.V., Leiden, The Netherlands
, Macaya DouoguihJanssen Vaccines & Prevention B.V., Leiden, The Netherlands
& the EBOVAC1 consortium
Pages 266-270
|
Published online: 25 Jan 2017
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.